News In Brief

Evolva confirm new CEO as company enters ‘next phase’ of evolution

By Nathan Gray contact

- Last updated on GMT

iStock
iStock
Oliver Walker will succeed Simon Waddington as CEO of Swiss-based biotech and fermentation specialists Evolva, as the company looks to push forward its commercial and operational activities.

Current CEO Simon Waddington has stepped down as CEO with immediate effect, and will support Oliver Walker as new CEO until he will leave the company towards the end of 2018.

Walker, who was previously CFO at Evolva and co-led the company’s strategic development, will retain his financial responsibilities with the current VP Finance Alessandro Del Fabro leading the financial operations.

With the major parts of restructuring are completed, Evolva says it will now enter the next phase of its development – with a strong focus on commercial and operational activities, including expanding the current product range with “ready-to-go-to-market” products and exploiting Evolva’s ability to rapidly go from product concept to commercial reality.

“On behalf of the whole board, I would like to thank Simon for all his efforts in building Evolva during the last seven years and especially to carry out the transformation during the last twelve months. We are confident that under Oliver’s leadership Evolva will further accelerate its activities to build the business and reach its true potential,”​ said Gerard Hoetmer, chairman of Evolva’s board of directors.

New CEO Walker will be physically located at Evolva’s headquarters in Reinach, Switzerland. Meanwhile Scott Fabro, Evolva’s current chief commercial officer will take on the role of COO and will be located in the USA – Evolva’s main market.

The company added that there is no near-term plans to expand the executive management team.

Related topics: Suppliers

Follow us

Featured Events

View more

Products

View more

Webinars